on liver ,to diagnose lsome liver disease and others.LFTs include many of the tests but sometimes they don’t measure the overall function of liver .Most commonly used tests are alanine transaminase (ALT) , aspartate aminotransferase (AST) , albumin , bilirubin tests and others may also includes ALT Test : (SGPT) Alanine aminotransferase is present in many
“All things are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy” (Jickells & Negrusz, 2012). In today’s society, the use and abuse of drugs can be seen in all populations and generations. The desire to obtain euphoria is a driving force in the abuse of drugs. The most prevalent drugs are plant based or synthetic counterparts; cannabis, cocaine, diamorphine, or heroin. As drugs become main stream, the Drug Enforcement Administration (DEA) is set with
Introduction Hepatitis B, an infectious disease caused by the Hepatitis B virus (HBV, a DNA virus), was formerly called serum hepatitis, inoculation hepatitis and post-transfusion hepatitis. Infection with HBV may result in acute, fulminant or chronic hepatitis, sometimes even resulting in a chronic asymptomatic carrier state, apart from hepatocellular carcinoma and liver cirrhosis (Davis 179). The disease is transmitted when an individual comes in contact with infected blood or objects. It may
DEFINITION (1) Cirrhosis can be simply defined as diffuse fibrosis associated with parenchymal nodules. It involves the whole liver rather than a small part even though on occasion the fibrosis may be more severe in one or other lobe. Fibrosis results partially from collapse of the new fibre formation and is usually regarded as a consequence of liver-cell necrosis. The nodules of a cirrhotic liver are the surviving parenchyma. But they are strutually altered. They vary greatly in size and appearance
A relatively newer biologic, rituximab provides an alternative strategy for treating the presenting patient. A genetically engineered chimeric anti-CD20 monoclonal antibody, rituximab exerts it therapeutic action by selectively targeting CD-20 positive B-cells1212, 18. As CD-20 is expressed exclusively on pre-B and mature B lymphocytes; stem cells and plasma cells are not implicated in rituximab therapy. The over expression of B-cells expressing the CD-20 surface antigen in the synovium of RA-affected